| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-07 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-07 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.2 | 7e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-07 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.18 | 8e-07 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |